Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 2/20 | 0.70 |
| ▸ | CYP19A1 | P11511 | 12/20 | 0.63 |
| ▸ | SERPINA6 | P08185 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.55 |
| ▸ | SHBG | P04278 | 1/20 | 0.54 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.54 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.54 |
| ▸ | PGR | P06401 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9549867 | 1.00 | AR (0.70) | ARCYP19A1SERPINA6CYP3A4SHBG | |
| SCHEMBL5708095 | 1.00 | AR (0.70) | ARCYP19A1SERPINA6CYP3A4SHBG | |
| SCHEMBL2733721 | 0.89 | CYP3A4 (0.69) | ARCYP19A1SERPINA6CYP3A4SHBG | |
| SCHEMBL10273391 | 0.89 | SERPINA6 (0.72) | ARCYP19A1SERPINA6CYP3A4SHBG | |
| SCHEMBL9066088 | 0.89 | SERPINA6 (0.72) | ARCYP19A1SERPINA6CYP3A4SHBG | |
| SCHEMBL9066081 | 0.89 | SERPINA6 (0.72) | ARCYP19A1SERPINA6CYP3A4SHBG | |
| SCHEMBL8645662 | 0.88 | CYP19A1 (0.63) | ARCYP19A1SERPINA6CYP3A4SHBG | |
| SCHEMBL8641139 | 0.88 | CYP19A1 (0.80) | ARCYP19A1SERPINA6CYP3A4SHBG | |
| SCHEMBL8645665 | 0.88 | CYP19A1 (0.63) | ARCYP19A1SERPINA6CYP3A4SHBG | |
| SCHEMBL8641143 | 0.88 | CYP19A1 (0.80) | ARCYP19A1SERPINA6CYP3A4SHBG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1422235-B1 | STEREOSELECTIVE METHOD OF PRODUCING 6ALPHA-FLUOROPREGNANES AND INTERMEDIARIES | RAGACTIVES SL (ES) | 2006-10-04 | — | — | EP | disclosed |
| US-20040181055-A1 | Stereoselective process for the production of 6alpha-fluorpregnanes and intermediates | RAGACTIVES, S.L. | 2004-09-16 | — | — | US | disclosed |
| EP-1422235-A1 | STEREOSELECTIVE METHOD OF PRODUCING 6ALPHA-FLUOROPREGNANES AND INTERMEDIARIES | Ragactives, S.L. (ES) | 2004-05-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040181055-A1 | Stereoselective process for the production of 6alpha-fluorpregnanes and intermediates | NR5A1, SRD5A2, SRD5A1 | AR 125/4885CYP19A1 15/4885SERPINA6 215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.